Covered recipient · General Payments record
PAUL MARINO
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,722.49
- Reported across 146 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $665.03 | 32 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $276.18 | 15 |
| Novo Nordisk AS | $238.25 | 9 |
| PFIZER INC. | $69.81 | 4 |
| Lilly USA, LLC | $38.42 | 2 |
| ITI, Inc. | $24.14 | 1 |
| Acerta Pharma LLC | $18.23 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (32)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.90 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107590739 | CMS |
| ABBVIE INC. | $19.86 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107590741 | CMS |
| ABBVIE INC. | $7.00 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107590743 | CMS |
| ABBVIE INC. | $10.00 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107590745 | CMS |
| ABBVIE INC. | $3.52 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107590747 | CMS |
| ABBVIE INC. | $105.30 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107590749 | CMS |
| ABBVIE INC. | $12.84 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107590751 | CMS |
| ABBVIE INC. | $3.18 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107590753 | CMS |
| ABBVIE INC. | $8.59 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107590755 | CMS |
| ABBVIE INC. | $4.68 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107590757 | CMS |
| ABBVIE INC. | $53.54 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107590759 | CMS |
| ABBVIE INC. | $3.66 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107590761 | CMS |
| ABBVIE INC. | $3.27 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107590763 | CMS |
| ABBVIE INC. | $9.29 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107590765 | CMS |
| ABBVIE INC. | $15.55 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107590767 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.23 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105576996 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $24.14 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143540650 | CMS |
| Lilly USA, LLC | $18.76 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135919792 | CMS |
| Lilly USA, LLC | $19.66 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135920226 | CMS |
| Novo Nordisk Inc | $23.37 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100517421 | CMS |
| Novo Nordisk Inc | $17.63 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100289804 | CMS |
| Novo Nordisk Inc | $2.67 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100528481 | CMS |
| Novo Nordisk Inc | $13.81 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100464072 | CMS |
| Novo Nordisk Inc | $14.31 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100252078 | CMS |
| Novo Nordisk Inc | $116.84 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100558225 | CMS |
| Novo Nordisk Inc | $9.15 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100586364 | CMS |
| Novo Nordisk Inc | $14.38 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100381937 | CMS |
| Novo Nordisk Inc | $26.09 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100427671 | CMS |
| PFIZER INC. | $18.86 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131718375 | CMS |
| PFIZER INC. | $16.35 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131718768 | CMS |
| PFIZER INC. | $18.49 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132007240 | CMS |
| PFIZER INC. | $16.11 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132108570 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.